Insights

Innovative Diagnostics ProPhase Labs is at the forefront of biotech innovation with its development of cutting-edge diagnostics and therapeutics for cancer detection and treatment, presenting strong opportunities for partnerships or supply of diagnostic materials.

Expanding Consumer Base The company's recent launch of DNA testing services and strategic hires in health and wellness highlight an increasing focus on direct-to-consumer health solutions, opening avenues for consumer product collaborations and channel expansion.

Strategic Collaborations Partnership with Forward Healthcare Consultants for cancer test commercialization indicates openness to alliances, creating opportunities for sales of diagnostic tools, lab services, or joint product development initiatives.

Investor Engagement Active participation in investment summits and roadshows signals strong investor interest, which can be leveraged to propose scalable solutions, supply chain enhancements, or technology integrations that support future growth.

Growth & Expansion Recent executive appointments and participation in major conferences reflect a focus on growth and market expansion in biotech and consumer health sectors, presenting prospects for acquiring new clients, partners, or distribution channels aligned with their strategic direction.

ProPhase Labs Tech Stack

ProPhase Labs uses 8 technology products and services including WP Rocket, Cloudflare CDN, MySQL, and more. Explore ProPhase Labs's tech stack below.

  • WP Rocket
    Caching
  • Cloudflare CDN
    Content Delivery Network
  • MySQL
    Database
  • WP Engine
    Platform As A Service
  • X-XSS-Protection
    Security
  • Google Analytics
    Web Analytics
  • OpenSSL
    Web Server Extensions
  • Nginx
    Web Servers

Media & News

ProPhase Labs's Email Address Formats

ProPhase Labs uses at least 1 format(s):
ProPhase Labs Email FormatsExamplePercentage
Last@prophaselabs.comDoe@prophaselabs.com
67%
FLast@prophaselabs.comJDoe@prophaselabs.com
22%
First_L@prophaselabs.comJohn_D@prophaselabs.com
5%
First@prophaselabs.comJohn@prophaselabs.com
6%

Frequently Asked Questions

What is ProPhase Labs's phone number?

Minus sign iconPlus sign icon
You can contact ProPhase Labs's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is ProPhase Labs's stock symbol?

Minus sign iconPlus sign icon
ProPhase Labs is a publicly traded company; the company's stock symbol is PRPH.

What is ProPhase Labs's official website and social media links?

Minus sign iconPlus sign icon
ProPhase Labs's official website is prophaselabs.com and has social profiles on LinkedInCrunchbase.

How much revenue does ProPhase Labs generate?

Minus sign iconPlus sign icon
As of December 2025, ProPhase Labs's annual revenue is estimated to be $21M.

What is ProPhase Labs's SIC code NAICS code?

Minus sign iconPlus sign icon
ProPhase Labs's SIC code is 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries NAICS code is 44-45 - Retail Trade.

How many employees does ProPhase Labs have currently?

Minus sign iconPlus sign icon
As of December 2025, ProPhase Labs has approximately 51 employees across 1 continents, including North America. Key team members include Ceo And Chairman: T. K.Chief Financial Officer: M. B.Chief Financial Officer: B. C.. Explore ProPhase Labs's employee directory with LeadIQ.

What industry does ProPhase Labs belong to?

Minus sign iconPlus sign icon
ProPhase Labs operates in the Retail industry.

What technology does ProPhase Labs use?

Minus sign iconPlus sign icon
ProPhase Labs's tech stack includes WP RocketCloudflare CDNMySQLWP EngineX-XSS-ProtectionGoogle AnalyticsOpenSSLNginx.

What is ProPhase Labs's email format?

Minus sign iconPlus sign icon
ProPhase Labs's email format typically follows the pattern of Last@prophaselabs.com. Find more ProPhase Labs email formats with LeadIQ.

How much funding has ProPhase Labs raised to date?

Minus sign iconPlus sign icon
As of December 2025, ProPhase Labs has raised $3M in funding. The last funding round occurred on Jul 23, 2025 for $3M.

ProPhase Labs

RetailNew York, United States51-200 Employees

ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and diagnostics company. Our goal is to create a healthier world with bold action and the power of insight. We’re revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, while developing potential game changer diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Our world-class CLIA labs and cutting-edge diagnostic technology provide wellness solutions for healthcare providers and consumers. We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives. We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach.

Section iconCompany Overview

Phone number
SIC Code
5122 - Drugs, Drug Proprietaries, and Druggists' Sundries
Stock Symbol
PRPH
NAICS Code
44-45 - Retail Trade
Employees
51-200

Section iconFunding & Financials

  • $3M

    ProPhase Labs has raised a total of $3M of funding over 3 rounds. Their latest funding round was raised on Jul 23, 2025 in the amount of $3M.

  • $25M$50M

    ProPhase Labs's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $3M

    ProPhase Labs has raised a total of $3M of funding over 3 rounds. Their latest funding round was raised on Jul 23, 2025 in the amount of $3M.

  • $25M$50M

    ProPhase Labs's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.